Latest news

 

Specialty drug labs in Mass. fail safety inspection

Surprise inspections at 37 specialty pharmacies show that only four have been fully complying with industry safety standards.

Patrick would bolster pharmacy oversight

After the outbreak of meningitis blamed on a Framingham business, more inspectors would scour compounding pharmacies under Governor Patrick’s proposed budget.

Owners drew $16m from pharmacy tied to deaths

The owners of the Framingham pharmacy blamed for a national fungal meningitis outbreak pulled millions of dollars out of the company in the last year.

Shutdown spurs hunt for medication sources

Hospitals and the government are trying to ensure an uninterrupted supply of critical drugs after the disclosure of problems with sterility procedures at Ameridose.

Rhonda Hall, who had a steroid injection, talked with Anurag Malani, infectious disease specialist at a Michigan hospital.

Jeff Kowalsky for the Boston Globe

A deadly puzzle, and then a breakthrough

Physicians across the US faced mysterious and seemingly isolated cases that were part of a meningitis outbreak linked to a Framingham compounding pharmacy.

About the meningitis outbreak

The deadly US outbreak of fungal meningitis, which has killed dozens and sickened hundreds, has been link to a steroid shots from a Framingham compounding pharmacy. The outbreak, which is likely to lead to a flood of lawsuits, has also led the state to revoke the license for the New England Compounding Center, and to step up surprise inspections at similar companies in the state.

Westborough pharmacy

The Ameridose facvility in Westborough.

Shutdown spurs hunt for medication sources

Hospitals and the government are trying to ensure an uninterrupted supply of critical drugs after the disclosure of problems with sterility procedures at Ameridose.

Hearings and investigations

New England Compounding Center co-owner Barry Cadden was sworn in at a congressional hearing, where he plead the Fifth.

Framingham firm’s owner pleads Fifth

Barry Cadden refused to testify at a congressional hearing on the meningitis outbreak, citing ongoing state and federal investigations.

Oversight and regulations

Lawsuits

Legal problems could multiply in meningitis outbreak

A nationwide meningitis outbreak linked to a Framingham drug compounding pharmacy is likely to cause a flood of lawsuits, according to legal specialists.